TopicalDosed ingredient Cosmetic cross-reference

Benzoyl Peroxide

CAS 94-36-0

Benzoyl Peroxide (CAS 94-36-0) is a Phase 4 pharmaceutical compound with 3 bioactivity targets and 198 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
3
SOURCE DrugCentral
Adverse signals
198
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Benzoyl Peroxide
CAS Number
94-36-0
UNII
W9WZN9A0GM
InChIKey
OMPJBNCRMGITSC-UHFFFAOYSA-N
ChEMBL ID
CHEMBL1200370
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
dosed ingredientnatural producttopical
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1200370 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE EMBL-EBI ChEMBL 3 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- AC50 27665.340625 nM 32 -
- Potency 82.4 nM 2 -
- IC50 19976.309999999998 nM 1 -
SOURCE DrugCentral 40 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Completed suicide 88 99.175 10010144
Broncholithiasis 14 85.143 10065037
Toxicity to various agents 104 75.17 10070863
Lymph node calcification 14 74.249 10056284
Choroiditis 16 70.639 10008792
Erythema 68 56.39 10015150
Swelling face 40 53.592 10042682
Lichen nitidus 8 51.001 10024428
Endophthalmitis 18 49.539 10014801
Bronchial wall thickening 14 49.054 10067182
Psoriasis 41 42.822 10037153
Application site erythema 15 41.102 10003041
Soft tissue necrosis 9 36.398 10065769
Eye pain 25 34.352 10015958
Visual acuity reduced 22 33.65 10047531
Intraocular pressure increased 15 33.504 10022806
Pneumomediastinum 11 33.343 10050184
Acne 21 32.583 10000496
Dry skin 30 32.296 10013786
Skin burning sensation 16 31.368 10054786
Polyarteritis nodosa 7 30.1 10036024
Pruritus 74 29.982 10037087
Chondritis 5 25.885 10008685
Skin irritation 13 24.444 10040880
Eye swelling 17 23.869 10015967
Post inflammatory pigmentation change 6 23.693 10036229
Dermatitis contact 12 22.391 10012442
Sexual abuse 5 21.967 10040461
Crime 4 21.616 10068954
Dystonia 14 21.092 10013983
Chemical burn of skin 4 20.552 10057941
Papule 10 20.262 10033733
Vision blurred 29 19.118 10047513
Drug clearance decreased 7 18.986 10049463
Personality change 10 18.745 10034719
Acute respiratory distress syndrome 17 17.821 10001052
Bladder discomfort 5 17.716 10005034
Dermatitis allergic 12 17.601 10012434
Pustule 6 17.293 10037578
Coronary artery stenosis 10 17.114 10011089

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 5 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
benzoyl peroxide 1418 SU MTHSPL
BENZOYL PEROXIDE 1418 SU MTHSPL
Benzoyl Peroxide 1418 SU MTHSPL
Benzoyl peroxide 1418 SU MTHSPL
benzoyl peroxide 1418 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Benzoyl Peroxide used for in pharmaceutical contexts?

Benzoyl Peroxide (CAS 94-36-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Benzoyl Peroxide?

Benzoyl Peroxide has 198 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Completed suicide, Broncholithiasis, Toxicity to various agents, Lymph node calcification, Choroiditis. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Benzoyl Peroxide also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Benzoyl Peroxide Regulatory & with EU status "restricted".

What clinical phase is Benzoyl Peroxide in?

Benzoyl Peroxide is rendered with ChEMBL max phase 4 (approved).